Botox cosmetic for lip and perioral enhancement

Dentistry Today

Volumn 28, Issue 5, 2009, Pages 94-97

  Gordon, Robert W ^a  

^a Clearwater Florida ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A;

ARTICLE; CASE REPORT; CUTANEOUS PARAMETERS; DENTAL CARE; FEMALE; HISTOLOGY; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; LIP; MIDDLE AGED; REJUVENATION;

BOTULINUM TOXIN TYPE A; ESTHETICS, DENTAL; FEMALE; HUMANS; INJECTIONS, INTRAMUSCULAR; LIP; MIDDLE AGED; REJUVENATION; SKIN AGING;

EID: 65649097619     PISSN: 87502186     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Botox Cosmetic and Botox (Botulinum Toxin Type A) By the Numbers. Allergan Press Release. 2008.
2. Top 5 surgical and nonsurgical cosmetic procedures. American Society for Aesthetic Plastic Surgery Web site. http://www.surgery.org/down- load/2006-Top5.pdf. Accessed March 17, 2009.
3. Niamtu J III. Cosmetic oral and maxillofacial sur- gery: the frame for cosmetic dentistry. Dent Today. Apr 2001;20:88-91.
4. Niamtu J III. Aesthetic uses of botulinum toxin A. J Oral Maxillofac Surg. 1999;57:1228-1233.
5. Fagien S. Botox for the treatment of dynamic and hyperkinetic facial lines and furrows: adjunctive use in facial aesthetic surgery. Plast Reconstr Surg. 1999;103:701-713.
6. Gordon RW. Vermilion Dollar Lips, Lip and Perioral Augmentation for the Cosmetic Dentist. Vermilion Dollar Publications; 2008.
7. Fagien S. Extended use of botulinum toxin type A in facial aesthetic surgery. Aesthetic Surg J. 1998;18:215-219.
8. Foster JA, Wulc AE. The use of botulinum A toxin to ameliorate facial dynamic lines. Int J Aesthet Restor Surg. 1996;4:137-144.
9. Botox Cosmetic [package insert]. Irvine, CA: Allergan, Inc; 2008.
10. Alam M, Dover JS, Arndt KA. Pain associated with injection of botulinum A exotoxin reconstituted using isotonic sodium chloride with and without preservative: a double-blind, randomized controlled trial. Arch Dermatol. 2002;138:510- 514.
11. Sposito MM. New Indications for botulinum toxin type A in cosmetics: mouth and neck. Plast Reconstr Surg. 2002;110:601-611.
12. Benedetto AV. The cosmetic uses of botulinum toxin type A. Int J Dermatol. 1999;38:641-655.
13. BOTOX [package Insert]. Irving, CA: Allergan; 2008.
14. Hexsel DM, De Almeida AT, Rutowitsch M, et al. Multicenter, double-blind study of the efficacy of Injections with botulinum toxin type A reconstitut- ed up to six consecutive weeks before applica- tion. Dermatol Surg. 2003;29:523-529.
15. Garcia A, Fulton JE Jr. Cosmetic denervation of the muscles of facial expression with botulinum toxin: a dose-response study. Dermatol Surg. 1996;22:39-43.
16. Carruthers A, Carruthers J, Procedures in Cosmetic Dermatology: Botulinum Toxin. Philadelphia, PA: Saunders; 2005.
17. Carruthers J, Fagien S, Matarasso SL, et al. Consensus recommendations on the use of botulinum toxin type A in facial aesthetics. Plast Reconstr Surg. 2004;114(suppl):1S-22S.
18. Jankovic J, Schwartz K. Response and immunoresistance to botulinum toxin injections. Neurology. 1995;45:1743-1746.
19. Ludlow CL, Hallett M, Rhew K, et al. Therapeutic use of type F botulinum toxin. N Engl J Med. 1992;326:349-350.
20. Sankhla C, Jankovic J, Duane D. Variability of the immunologic and clinical response in dystonic patients immunoresistant to botulinum toxin injections. Mov Disord. 1998;13:150-154.
21. Matarasso SL. Complications of botulinum A exotoxin for hyperfunctional lines. Dermatol Surg. 1998;24:1249-1254.
22. Carruthers A, Carey W, De Lorenzl C, et al. Randomized, double-blind comparison of the efficacy of two hyaluronic acid derivatives, restylane perlane and hylaform, In the treatment of nasolabial folds. Dermatol Surg. 2005;31:1591- 1598.
23. Kim EJ, Reeck JB, Maas CS. A validated rating scale for hyperkinetic facial lines. Arch Facial Plast Surg. 2004;6:253-256.
24. Kim EJ, Ramirez AL, Reeck JB, et al. The role of botulinum toxin type B (Myobioc) in the treatment of hyperkinetic facial lines. Plast Reconstr Surg. 2003;112(suppl):88S-93S.
25. Carruthers A, Carruthers J. Use of botulinum toxin A for facial enhancement. In: Klein AW, ed. Tissue Augmentation In Clinical Practice. 2nd ed. New York, NY: Taylor & Francis Group; 2006.
26. Meunier FA, Schiavo G, Molgo J, Botulinum neu- rotoxins: from paralysis to recovery of functional neuromuscular transmission, J Physiol Paris. 2002;96:105-113.
27. Humeau Y, Doussau F, Grant NJ, et al. How botulinum and tetanus neurotoxins block neurotransmitter release. Biochimie. 2000;82:427-446.